| Product Code: ETC9216369 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Pharmacogenetic Testing Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Serbia Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Serbia Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Serbia Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Serbia Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Serbia Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Serbia Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Serbia Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Serbia Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Serbia Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of personalized medicine in Serbia |
4.2.2 Rising prevalence of chronic diseases driving the demand for pharmacogenetic testing |
4.2.3 Growing awareness among healthcare professionals and patients about the benefits of pharmacogenetic testing |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals for conducting pharmacogenetic testing |
4.3.2 High cost associated with pharmacogenetic testing limiting its accessibility to a wider population |
4.3.3 Lack of clear regulations and guidelines governing pharmacogenetic testing in Serbia |
5 Serbia Pharmacogenetic Testing Market Trends |
6 Serbia Pharmacogenetic Testing Market, By Types |
6.1 Serbia Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Serbia Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Serbia Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Serbia Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Serbia Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Serbia Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Serbia Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Serbia Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Serbia Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Serbia Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Serbia Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Serbia Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Serbia Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Serbia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Serbia Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Serbia Pharmacogenetic Testing Market Export to Major Countries |
7.2 Serbia Pharmacogenetic Testing Market Imports from Major Countries |
8 Serbia Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare institutions offering pharmacogenetic testing services |
8.2 Percentage of patients opting for pharmacogenetic testing in Serbia |
8.3 Rate of adoption of pharmacogenetic testing by healthcare professionals |
9 Serbia Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Serbia Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Serbia Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Serbia Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Serbia Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Serbia Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Serbia Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Serbia Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Serbia Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Serbia Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Serbia Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here